Skip to content

Study · Not a test of the peptide alone · 2011

1 result

Design and characterization of a fluorescent ghrelin analog for imaging the growth hormone secretagogue receptor 1a.

McGirr R, McFarland MS, McTavish J, Luyt LG, Dhanvantari S

Regulatory peptides3 Sept 2011Cited by 46 (Europe PMC)

PMID21893106 (opens in a new tab)DOI10.1016/j.regpep.2011.08.011 (opens in a new tab)PepBankPUB-21893106
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Hexarelin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Hexarelin.

  1. 01LabNot a test of Hexarelin aloneEx vivo tissueMechanism

    In heart tissue in situ, hexarelin displaced the specific binding of the fluorescent ghrelin analog fluorescein-ghrelin(1-18).

    In plain wordsIn lab tests on heart tissue, hexarelin pushed a fluorescent ghrelin probe off its receptor, as ghrelin also did.

    Peptide
    Hexarelin
    Outcome
    DecreaseDisplacement of fluorescent ghrelin probe binding in heart tissue
    Study

    n: not reported in source

    heart tissue in situ with fluorescein-ghrelin(1-18)
    Outcome group
    Receptor activity and mechanism · Cardiovascular

    Source sentences

    Summary
    Finally, we demonstrate that fluorescein-ghrelin(1-18) binds specifically to heart tissue in situ, and its binding is displaced by both wt ghrelin and hexarelin.

    In this study, Hexarelin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Hexarelin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 21:44 UTC

    Study results updated

  2. Version 1

    13 Oct 2026, 16:31 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.